Market Analysis and Insights:
The global Clinical Trial Imaging market size is projected to reach US$ 2197.88 million by 2028, from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028.
Fully considering the economic change by this health crisis, In-house Imaging Service accounting for 30.61% of the Clinical Trial Imaging global market in 2021, is projected to value US$ 598.79 million by 2028, growing at a revised 5.05% CAGR between 2022 and 2028. While Pharmaceutical Companies segment is altered to an 7.33% CAGR throughout this forecast period.
China Clinical Trial Imaging market size was US$ 136.53 million in 2021, while the North America and Europe Clinical Trial Imaging were US$ 459.63 million and US$ 374.96 million, severally. The proportion of the North America was 33.32% in 2021, while China and Europe were 9.90% and 27.18% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 8.54% through the analysis period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trial Imaging market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trial Imaging market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial Imaging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial Imaging market.
Scope and Market Size:
Clinical Trial Imaging market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Clario
- ICON
- McLaren
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
Segment by Type
- In-house Imaging Service
- Central Imaging Service
Segment by Application
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
By Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- India
- Southeast Asia
- Korea
- Australia
- Rest of Asia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- South America
- Brazil
- Rest of South America
- Middle East & Africa
- GCC Countries
- Turkey
- South Africa
- Rest of MEA
TABLE OF CONTENTS
1 REPORT OVERVIEW
- 1.1 STUDY SCOPE
- 1.2 MARKET ANALYSIS BY TYPE
- 1.2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
- 1.2.2 IN-HOUSE IMAGING SERVICE
- 1.2.3 CENTRAL IMAGING SERVICE
- 1.3 MARKET BY APPLICATION
- 1.3.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
- 1.3.2 PHARMACEUTICAL COMPANIES
- 1.3.3 BIOTECHNOLOGY COMPANIES
- 1.3.4 ACADEMIC INSTITUTES
- 1.3.5 OTHERS
- 1.4 STUDY OBJECTIVES
- 1.5 YEARS CONSIDERED
2 GLOBAL GROWTH TRENDS
- 2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET PERSPECTIVE (2017-2028)
- 2.2 CLINICAL TRIAL IMAGING GROWTH TRENDS BY REGION
- 2.2.1 CLINICAL TRIAL IMAGING MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
- 2.2.2 CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY REGION (2017-2022)
- 2.2.3 CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY REGION (2023-2028)
- 2.3 CLINICAL TRIAL IMAGING MARKET DYNAMICS
- 2.3.1 CLINICAL TRIAL IMAGING INDUSTRY TRENDS
- 2.3.2 CLINICAL TRIAL IMAGING MARKET DRIVERS
- 2.3.3 CLINICAL TRIAL IMAGING MARKET CHALLENGES
- 2.3.4 PORTER'橲 FIVE FORCES ANALYSIS
3 COMPETITION LANDSCAPE BY KEY PLAYERS
- 3.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE
- 3.1.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE (2017-2022)
- 3.1.2 GLOBAL CLINICAL TRIAL IMAGING REVENUE MARKET SHARE BY PLAYERS (2017-2022)
- 3.2 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
- 3.3 PLAYERS COVERED: RANKING BY CLINICAL TRIAL IMAGING REVENUE
- 3.4 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO
- 3.4.1 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO (CR5)
- 3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY CLINICAL TRIAL IMAGING REVENUE IN 2021
- 3.5 CLINICAL TRIAL IMAGING KEY PLAYERS HEAD OFFICE AND AREA SERVED
- 3.6 ESTABLISHED DATE OF CLINICAL TRIAL IMAGING MARKET PLAYERS
- 3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS
4 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY TYPE
- 4.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY TYPE (2017-2022)
- 4.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY TYPE (2023-2028)
5 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY APPLICATION
- 5.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 5.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
6 NORTH AMERICA
- 6.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
- 6.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
- 6.2.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
- 6.2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
- 6.2.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
- 6.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
- 6.3.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
- 6.3.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
- 6.3.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
- 6.4 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
- 6.4.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
- 6.4.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY COUNTRY (2023-2028)
- 6.4.3 UNITED STATES
- 6.4.4 CANADA
- 6.4.5 MEXICO
7 EUROPE
- 7.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
- 7.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
- 7.2.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
- 7.2.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
- 7.2.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
- 7.3 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
- 7.3.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
- 7.3.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
- 7.3.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
- 7.4 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
- 7.4.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
- 7.4.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
- 7.4.3 GERMANY
- 7.4.4 FRANCE
- 7.4.5 U.K.
- 7.4.6 ITALY
- 7.4.7 RUSSIA
- 7.4.8 NORDIC COUNTRIES
8 ASIA-PACIFIC
- 8.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
- 8.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
- 8.2.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
- 8.2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
- 8.2.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
- 8.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
- 8.3.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
- 8.3.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
- 8.3.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
- 8.4 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION
- 8.4.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2017-2022)
- 8.4.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2023-2028)
- 8.4.3 CHINA
- 8.4.4 JAPAN
- 8.4.5 KOREA
- 8.4.6 SOUTHEAST ASIA
- 8.4.7 INDIA
- 8.4.8 AUSTRALIA
9 SOUTH AMERICA
- 9.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
- 9.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
- 9.2.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
- 9.2.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
- 9.2.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
- 9.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
- 9.3.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
- 9.3.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
- 9.3.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
- 9.4 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
- 9.4.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
- 9.4.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
- 9.4.3 BRAZIL
10 MIDDLE EAST & AFRICA
- 10.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
- 10.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
- 10.2.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
- 10.2.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
- 10.2.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
- 10.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
- 10.3.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
- 10.3.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
- 10.3.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
- 10.4 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
- 10.4.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
- 10.4.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
- 10.4.3 GCC COUNTRIES
- 10.4.4 TURKEY
- 10.4.5 SOUTH AFRICA
11 KEY PLAYERS PROFILES
- 11.1 CLARIO
- 11.1.1 CLARIO COMPANY DETAILS
- 11.1.2 CLARIO BUSINESS OVERVIEW
- 11.1.3 CLARIO CLINICAL TRIAL IMAGING INTRODUCTION
- 11.1.4 CLARIO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.1.5 CLARIO RECENT DEVELOPMENT
- 11.2 ICON
- 11.2.1 ICON COMPANY DETAILS
- 11.2.2 ICON BUSINESS OVERVIEW
- 11.2.3 ICON CLINICAL TRIAL IMAGING INTRODUCTION
- 11.2.4 ICON REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.2.5 ICON RECENT DEVELOPMENT
- 11.3 MCLAREN
- 11.3.1 MCLAREN COMPANY DETAILS
- 11.3.2 MCLAREN BUSINESS OVERVIEW
- 11.3.3 MCLAREN CLINICAL TRIAL IMAGING INTRODUCTION
- 11.3.4 MCLAREN REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.3.5 MCLAREN RECENT DEVELOPMENT
- 11.4 PAREXEL
- 11.4.1 PAREXEL COMPANY DETAILS
- 11.4.2 PAREXEL BUSINESS OVERVIEW
- 11.4.3 PAREXEL CLINICAL TRIAL IMAGING INTRODUCTION
- 11.4.4 PAREXEL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.4.5 PAREXEL RECENT DEVELOPMENT
- 11.5 BIOTELEMETRY
- 11.5.1 BIOTELEMETRY COMPANY DETAILS
- 11.5.2 BIOTELEMETRY BUSINESS OVERVIEW
- 11.5.3 BIOTELEMETRY CLINICAL TRIAL IMAGING INTRODUCTION
- 11.5.4 BIOTELEMETRY REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.5.5 BIOTELEMETRY RECENT DEVELOPMENT
- 11.6 PROSCAN IMAGING
- 11.6.1 PROSCAN IMAGING COMPANY DETAILS
- 11.6.2 PROSCAN IMAGING BUSINESS OVERVIEW
- 11.6.3 PROSCAN IMAGING CLINICAL TRIAL IMAGING INTRODUCTION
- 11.6.4 PROSCAN IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.6.5 PROSCAN IMAGING RECENT DEVELOPMENT
- 11.7 IMAGING ENDPOINTS
- 11.7.1 IMAGING ENDPOINTS COMPANY DETAILS
- 11.7.2 IMAGING ENDPOINTS BUSINESS OVERVIEW
- 11.7.3 IMAGING ENDPOINTS CLINICAL TRIAL IMAGING INTRODUCTION
- 11.7.4 IMAGING ENDPOINTS REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.7.5 IMAGING ENDPOINTS RECENT DEVELOPMENT
- 11.8 RADIANT SAGE
- 11.8.1 RADIANT SAGE COMPANY DETAILS
- 11.8.2 RADIANT SAGE BUSINESS OVERVIEW
- 11.8.3 RADIANT SAGE CLINICAL TRIAL IMAGING INTRODUCTION
- 11.8.4 RADIANT SAGE REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.9 MICRON, INC.
- 11.9.1 MICRON, INC. COMPANY DETAILS
- 11.9.2 MICRON, INC. BUSINESS OVERVIEW
- 11.9.3 MICRON, INC. CLINICAL TRIAL IMAGING INTRODUCTION
- 11.9.4 MICRON, INC. REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.9.5 MICRON, INC. RECENT DEVELOPMENT
- 11.10 INTRINSIC IMAGING
- 11.10.1 INTRINSIC IMAGING COMPANY DETAILS
- 11.10.2 INTRINSIC IMAGING BUSINESS OVERVIEW
- 11.10.3 INTRINSIC IMAGING CLINICAL TRIAL IMAGING INTRODUCTION
- 11.10.4 INTRINSIC IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.10.5 INTRINSIC IMAGING RECENT DEVELOPMENT
- 11.11 MEDIAN TECHNOLOGIES
- 11.11.1 MEDIAN TECHNOLOGIES COMPANY DETAILS
- 11.11.2 MEDIAN TECHNOLOGIES BUSINESS OVERVIEW
- 11.11.3 MEDIAN TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION
- 11.11.4 MEDIAN TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.11.5 MEDIAN TECHNOLOGIES RECENT DEVELOPMENT
- 11.12 CARDIOVASCULAR IMAGING TECHNOLOGIES
- 11.12.1 CARDIOVASCULAR IMAGING TECHNOLOGIES COMPANY DETAILS
- 11.12.2 CARDIOVASCULAR IMAGING TECHNOLOGIES BUSINESS OVERVIEW
- 11.12.3 CARDIOVASCULAR IMAGING TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION
- 11.12.4 CARDIOVASCULAR IMAGING TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.13 BANOOK MEDICAL
- 11.13.1 BANOOK MEDICAL COMPANY DETAILS
- 11.13.2 BANOOK MEDICAL BUSINESS OVERVIEW
- 11.13.3 BANOOK MEDICAL CLINICAL TRIAL IMAGING INTRODUCTION
- 11.13.4 BANOOK MEDICAL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.13.5 BANOOK MEDICAL RECENT DEVELOPMENT
- 11.14 IXICO
- 11.14.1 IXICO COMPANY DETAILS
- 11.14.2 IXICO BUSINESS OVERVIEW
- 11.14.3 IXICO CLINICAL TRIAL IMAGING INTRODUCTION
- 11.14.4 IXICO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
- 11.14.5 IXICO RECENT DEVELOPMENT
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
- 13.1 RESEARCH METHODOLOGY
- 13.1.1 METHODOLOGY/RESEARCH APPROACH
- 13.1.2 DATA SOURCE
- 13.2 DISCLAIMER
- 13.3 AUTHOR DETAILS